Desentum Competitors and Similar CompaniesClear all
Desentum's competitors and similar companies include Allergopharma, Allergon, Cipla and UCB.
 Desentum Desentum is a biopharmaceutical company developing allergen immunotherapy products (allergy vaccines). |  Allergon Allergon is a company producing a variety of allergen source materials, including moulds, mites, epithelia, and food allergens. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2011 | Founding Date 1969 | Founding Date 1963 | Founding Date 1935 | Founding Date 1928 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Espoo, FI HQ Helsinki, FI | Locations Reinbek, DE HQ Wien, AT Reinbek, DE Przyszowice, PL Madrid, ES Hünenberg, CH Istanbul, TR | Locations Ängelholm, SE HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 1110% increase | Employees 2051% increase | Employees 254% decrease | Employees 27,764 | Employees 9,052 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr130.6m (FY, 2021) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods kr88.7m (FY, 2021) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr41.8m (FY, 2021) | Gross profit ₹195b (FY, 2026) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income kr3.5m (FY, 2021) | Net income ₹38.7b (FY, 2026) | Net income €1.6b (FY, 2025) |
Operating ⚠ | |||||
Trademarks | Trademarks N/A | Trademarks 87 (Nov, 2022) | Trademarks 6 (Nov, 2022) | Trademarks N/A | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Allergopharma
HQ
Reinbek, DE
Allergopharma is a company engaged in the field of allergen immunotherapy (AIT).
View companyAllergon
HQ
Ängelholm, SE
Allergon is a company producing a variety of allergen source materials, including moulds, mites, epithelia, and food allergens.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company